Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001213900-20-015637

Director bought 314,066 shares at $5.00 ($1,570,330)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ferneau Philip Director 2020-06-19 Purchase +64,066 $5.00 $320,330 2,348,976 I
Ferneau Philip Director 2020-06-19 Purchase +250,000 $5.00 $1,250,000 400,280 I
Open-market purchases · 314,066 sh · avg $5.00 · $1,570,330
Loading xslF345X03/ownership.xml…